Cerebras Systems Inc. (CBRS) Stock Price & Analysis
Cerebras Systems Inc. (CBRS) closed at USD 108.94 on Thursday, October 22, 2026, down 7.66% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 117.98; the Oct 22, 2026 session ranged USD 107.9–114.19 on volume of 11,097,296 shares. Market capitalization is $25.88B, with a 52-week range of USD 107.9–386.34 (NMS). Source: Nexqual, retrieved October 23, 2026 at 08:37 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CBRS.md
Key facts (CBRS)
- 1 of 80 tracked superinvestors hold CBRS (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.73 on a 1–5 scale) (11 analysts), mean target USD 282.55 (range 175–330).
- Total return with dividends: 1Y -65.0% vs S&P 500 +14.9%; 5Y -61.0% vs S&P 500 +80.3%.
- Next earnings: 2026-11-12, EPS estimate USD -0.14, revenue estimate $215M.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CBRS)
P/S 44.9x · EV/Sales 32.8x · P/B 2.8x · FCF yield -3.50% · Earnings yield -0.69% · Net cash $7.00B · EV $18.9B
Superinvestors (SEC 13F-HR, Q2 2026) (CBRS)
1 of 80 tracked investors hold CBRS. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Chase Coleman | Tiger Global Management | 2.76% | $663M | New position |
Analysts (CBRS)
Consensus Buy (mean 1.73 on a 1–5 scale), 11 analysts; mean target USD 282.55 (low 175, high 330).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | TD Cowen | Target lowered | Buy | $275 → $175 |
| 2026-10-02 | Freedom Capital Markets | Upgrade | Hold → Buy | $209 |
| 2026-09-14 | Freedom Capital Markets | Maintained | Hold | $209 |
| 2026-08-19 | Rosenblatt | Maintained | Buy | $300 |
| 2026-08-19 | Needham | Reiterated | Buy | $300 |
| 2026-08-13 | UBS | Target raised | Buy | $320 → $330 |
| 2026-08-13 | Citigroup | Target lowered | Buy | $340 → $320 |
| 2026-08-13 | Wedbush | Target raised | Outperform | $280 → $290 |
| 2026-08-13 | Mizuho | Target lowered | Outperform | $310 → $300 |
| 2026-08-13 | Rosenblatt | Maintained | Buy | $300 |
| 2026-08-13 | Morgan Stanley | Target raised | Overweight | $273 → $279 |
| 2026-08-13 | Needham | Reiterated | Buy | $300 |
Total return (dividends reinvested) (CBRS)
| 1Y (from 2026-05-14) | 5Y (from 2026-05-11) | |
|---|---|---|
| Total return | -65.0% | -61.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | — | — |
| Volatility (annualized) | 112.5% | 92.5% |
| Max drawdown | -65.0% (May 2026→Oct 2026) | -61.0% (May 2026→Oct 2026) |
CBRS revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Service | $126.0M | 70.0% | +281.5% |
| Product | $54.1M | 30.0% | -23.0% |
| Total revenue | $180.1M | 100% | — |
CBRS revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Europe, Middle East, and Africa | $95.7M | 53.2% | +31.1% |
| United States | $84.0M | 46.6% | +178.0% |
| Other | $384,000 | 0.2% | +398.7% |
| Total revenue | $180.1M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
CBRS customer concentration
In the period ended Jun 30, 2026, 3 direct customers each accounted for at least 10% (34%, 32%, 10%) of revenue, per the company's 10-Q filed Aug 12, 2026. The company does not name them.
CBRS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.14 | $-0.32 | -56.2% | $214.7M | 10 |
| Next quarter (ends Dec 2026) | $-0.23 | $-0.38 | -40.6% | $274.4M | 10 |
| Current fiscal year (ends Dec 2026) | $-0.47 | $-0.97 | -51.6% | $887.1M | 11 |
| Next fiscal year (ends Dec 2027) | $1.27 | $0.96 | +33.1% | $2.95B | 11 |
CBRS options: expected move
Options price a move of about ±18.7% (±$20.10) by Nov 13, 2026, which includes earnings on Nov 12, 2026; the earnings reaction alone is priced at about ±9.1%. Over the last 2 reports the stock moved ±10.2% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 90.4% | ±10.8% |
| Nov 6, 2026 | 14 | 83.5% | ±13.6% |
| Nov 13, 2026 | 21 | 93.7% | ±18.7% |
| Nov 20, 2026 | 28 | 93.4% | ±21.4% |
| Nov 27, 2026 | 35 | 88.3% | ±22.5% |
| Dec 4, 2026 | 42 | 87.6% | ±24.4% |
| Dec 18, 2026 | 56 | 84.4% | ±27.1% |
| Jan 15, 2027 | 84 | 81.1% | ±31.6% |
30-day implied volatility 92.3% vs 72.8% realized over the last 30 trading days. Put/call ratio (volume) 1.39. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 08:37 UTC)
| Price | USD 108.94 |
|---|---|
| Change | ▼ 7.66% (down) |
| Previous Close | USD 117.98 |
| Open | USD 113.96 |
| Day Range | USD 107.9 – 114.19 |
| 52-Week Range | USD 107.9 – 386.34 |
| Volume | 11,097,296 shares |
| Market Cap | $25.88B |
| Exchange | NMS |
Technical Analysis (CBRS)
Nexqual's technical model rates CBRS "SELL" based on 2 bullish and 5 bearish signals across 112 daily candles, as of October 23, 2026 at 08:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 18.15 (oversold) |
| vs SMA50 | Below (USD 182.26) |
| MACD | -20.49 (negative) |
Analyst Ratings (CBRS)
Wall Street analysts rate CBRS "Buy" based on 11 analysts, with a mean price target of USD 282.55 (range USD 175–330), per Nexqual as of October 23, 2026 at 08:37 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 282.55 |
| High Target | USD 330 |
| Low Target | USD 175 |
| Buy / Hold / Sell | 11 / 0 / 0 |
Earnings (CBRS)
| Next Earnings Date | 2026-11-12 |
|---|---|
| EPS Estimate | USD -0.14 |
| Revenue Estimate | $214.70M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.05 vs est -0.18 ▲ beat |
| 2026-03-31 | USD -0.04 vs est -0.15 ▲ beat |
Source: Nexqual, October 23, 2026 at 08:37 UTC.
Financials & Fundamentals (CBRS)
| Total Revenue | $680.67M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +74.30% |
| Gross Margin | +34.90% |
| Operating Margin | -264.97% |
| Profit Margin | -75.27% |
| Debt / Equity | 0.16 |
| Current Ratio | 5.83 |
| Total Cash | $7.92B |
| Total Debt | $1.49B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$905.30M (-157.1% of revenue) |
Source: Nexqual, October 23, 2026 at 08:37 UTC.
Financial Health Score (CBRS)
Nexqual rates Cerebras Systems Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 08:37 UTC.
| Growth | Strong — Revenue +74% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $7.92B cash and investments vs $918M debt (Jun 2026, SEC), net cash |
| Cash Flow | Weak — FCF negative: -$905M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Mixed — No data |
Ownership (CBRS)
| Insider Ownership | +9.60% |
|---|---|
| Institutional Ownership | +80.36% |
| Shares Outstanding | 112.25M |
| Float | 109.90M |
| Short % of Float | +12.58% |
Source: Nexqual, October 23, 2026 at 08:37 UTC.
Leadership (CBRS)
Cerebras Systems Inc. is led by Andrew D. Feldman, Co-Founder, CEO, President & Chairman, per Nexqual as of October 23, 2026 at 08:37 UTC.
| Co-Founder, CEO, President & Chairman | Andrew D. Feldman |
|---|---|
| Co-Founder & CTO | Sean Lie |
| Chief Operating Officer | Dhiraj Mallick |
| CTO, Emeritus & Co-Founder | Gary Lauterbach |
| Senior VP, CFO & Treasurer | Robert Patrick Komin |
Major Backers & Investors (CBRS)
Notable institutional backers of Cerebras Systems Inc. include Eclipse Operations, LLC, FMR, LLC, Altimeter Capital Management, LP, according to Nexqual as of October 23, 2026 at 08:37 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Eclipse Operations, LLC | 10.2% |
| FMR, LLC | 7.51% |
| Altimeter Capital Management, LP | 6.44% |
| Coatue Management | 6.25% |
| Fidelity | 4.82% |
| Capital Group | 3.47% |
| Morgan Stanley | 2.87% |
| Atreides Management, LP | 2.77% |
Source: Nexqual, October 23, 2026 at 08:37 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GFS | GlobalFoundries Inc. | USD 43.37 | ▼ 9.08% |
| ON | ON Semiconductor Corporation | USD 73.23 | ▼ 4.82% |
| CRDO | Credo Technology Group Holding | USD 162.77 | ▼ 10.7% |
| TSEM | Tower Semiconductor Ltd. | USD 167.71 | ▼ 11.52% |
| MTSI | MACOM Technology Solutions Hold | USD 229.73 | ▼ 15.87% |
| SWKS | Skyworks Solutions, Inc. | USD 82.39 | ▲ 0.21% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 08:37 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt